Method for providing information on ulcerative colitis and a device using the same

JP2026539056APending Publication Date: 2026-11-19IND ACADEMIC COOP FOUND YONSEI UNIV +6
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2026524862
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-10-27
Filing Date
2024-10-25
Publication Date
2026-11-19

Smart Images

  • Figure 2026539056000001_ABST
    Figure 2026539056000001_ABST
Patent Text Reader

Abstract

This specification provides a method for providing information on ulcerative colitis embodied by a processor, comprising the steps of receiving a K-UCSQ (Korean Ulcerative Colitis-Specific Questionnaire) score for an individual, and determining the prognosis for inflammatory bowel disease for the individual based on the received K-UCSQ score.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] [1] The present invention relates to an information providing method related to ulcerative colitis (UC) and a device using the same.

BACKGROUND ART

[0002] [2] Inflammatory bowel disease (IBD) is a disease that causes chronic inflammation of unknown cause in the intestinal tract, and exhibits a clinical course that progresses while repeating exacerbations and remissions. Such inflammatory bowel diseases include two main types: ulcerative colitis (UC) and Crohn's disease (CD). These two inflammatory bowel diseases share common features such as similar symptoms including abdominal pain and diarrhea, and responsiveness to treatments such as steroids and immunosuppressants.

[0003] [3] However, ulcerative colitis and Crohn's disease differ in genetic background and pathophysiology, and have different characteristic clinical manifestations such as invasive sites and complications, so there are differences in treatment methods.

[0004] [4] More specifically, ulcerative colitis is characterized by inflammation localized in the mucosa and submucosa of the large intestine, and mostly affects the rectum, presenting continuous lesions that progress proximally. As endoscopic findings, mucosal redness, edema, loss of visible vascular pattern, granularity, erosion, bleeding, ulcers and the like are variously observed according to the severity of the disease, and it is characterized in that the boundary between the normal site and the inflamed site is clearly distinguished.

[0005] [5] On the other hand, Crohn's disease can affect the entire gastrointestinal tract from the oral cavity to the anus, and can invade all layers of the intestinal wall, so complications such as stenosis and fistula often occur. Characteristic endoscopic findings include non-continuous appearance of longitudinal ulcers, cobblestone-like appearance, or aphthous ulcers arranged in longitudinal rows, which mainly affect the ileocecal region and are often accompanied by anal lesions.

[0006] [6] However, atypical cases are not uncommon in patients with ulcerative colitis, and endoscopic findings are often ambiguous, making clinical differentiation between the two diseases difficult. Ultimately, differential diagnosis of the disease is crucial in the treatment and prognosis of ulcerative colitis, and a differentiated therapeutic approach is necessary accordingly.

[0007] [7] The background technology of the invention is prepared to make the invention easier to understand. It should not be understood that the matters described in the background technology of the invention are recognized as prior art. [Overview of the Initiative] [Problems that the invention aims to solve]

[0008] [8] On the other hand, ulcerative colitis and Crohn's disease are treated with remission induction therapy, which improves acute symptoms, reduces mucosal inflammation, and leads to remission, and remission maintenance therapy, which maintains remission for a long period without disease relapse, with the ultimate goal being to improve the patient's health and quality of life.

[0009] [9] However, ulcerative colitis differs from Crohn's disease in terms of the site of invasion and clinical severity, and therefore the treatment methods also differ.

[10] More specifically, in the treatment of ulcerative colitis, local agents such as suppositories are recommended as first-line treatment for proctitis that is not severe, oral preparations alone or in combination with local preparations are recommended for left-sided colitis or extensive colitis, and hospitalization and intravenous administration of steroids may be recommended for severe and fulminant colitis.

[0010]

[11] However, in the treatment of Crohn's disease, for stiff to moderate cases, budesonide or mesalamine (5-Aminosalicylic acid) may be recommended as first-line treatment, and for moderate to severe cases, combination therapy with immunomodulators in addition to steroids may be recommended.

[0011]

[12] Ultimately, ulcerative colitis and Crohn's disease differ pathophysiologically, as mentioned above, and therefore require different treatments and evaluation methods.

[0012]

[13] However, ulcerative colitis and Crohn's disease are now considered as subtypes of inflammatory bowel disease, and the quality of life due to the disease and treatment is similarly assessed by one of the IBDQs (Inflammatory Bowel Disease Questionnaires).

[0013]

[14] The IBDQ was developed in 1989 and has been a responsive and reliable assessment tool in previous studies. However, because ulcerative colitis and Crohn's disease have different symptoms and treatments, the IBDQ has limitations in that it does not adequately reflect the state and quality of life associated with ulcerative colitis.

[0014]

[15] Recognizing the need for an assessment tool specifically for ulcerative colitis, the inventors of the present invention found that toilet-related aspects of the characteristic symptoms and maintenance of remission of ulcerative colitis have a significant impact on the lives of patients with ulcerative colitis.

[0015]

[16] As a result, the inventors have developed a reliable assessment tool that can more accurately assess quality of life related to ulcerative colitis than the conventional assessment tool IBDQ by adding items related to the toilet area.

[0016]

[17] Therefore, another problem that the present invention seeks to solve is to provide an information-providing method and a device based thereon that can predict and evaluate the state and prognosis of inflammatory colitis, in particular ulcerative colitis.

[0017]

[18] The problems that the present invention will not address are limited to those described above, and other problems not mentioned will be clearly understood by those skilled in the art from the following description. [Means for solving the problem]

[0018]

[19] In order to solve the problems described above, the present invention provides a method for providing information on ulcerative colitis (UC) embodied by a processor, comprising the steps of receiving a K-UCSQ (Korean Ulcerative Colitis-Specific Questionnaire) score for an individual, and determining the prognosis of inflammatory bowel disease for the individual based on the received K-UCSQ score.

[0019]

[20] According to the features of the present invention, inflammatory bowel disease may include, but is not limited to, ulcerative colitis (UC) and Crohn's disease (CD).

[0020]

[21] According to other features of the present invention, the determination step may include determining that the lower the received K-UCSQ score, the more negative the overall health prognosis associated with ulcerative colitis for the individual.

[0021]

[22] According to yet another feature of the present invention, the determination step may include determining that the higher the received K-UCSQ score, the more positive the individual's quality of life related to ulcerative colitis.

[0022]

[23] According to another feature of the present invention, quality of life may be, but is not limited to, the quality of life during the two weeks prior to the measurement of the K-UCSQ score.

[24] According to still another feature of the present invention, the K-UCSQ may include questions related to at least one of a general health status domain, a bowel symptoms domain, a lavatory domain, a functional symptoms domain, and an impact on daily life domain.

[0023]

[25] According to still another feature of the present invention, the bowel symptoms domain may include questions related to at least one of defecation frequency, defecation state, presence or absence of bloody stool, amount of bloody stool, and fecal incontinence.

[26] According to still another feature of the present invention, the lavatory domain may include questions related to at least one of defecation stress, anxiety about the availability of a lavatory, ease of access to a lavatory, presence or absence of urgency to defecate, and lavatory location.

[0024]

[27] According to still another feature of the present invention, the functional symptoms domain may include questions related to at least one of the frequency of abdominal pain, presence or absence of pain other than abdominal pain, location of abdominal pain, presence or absence of abdominal gas, fatigue, poor physical condition, and frequency of stress.

[0025]

[28] According to still another feature of the present invention, the impact on daily life domain may include questions related to at least one of sleep state, eating state, emotional state, self-denial, suicidal ideation, depressive state, social activities, housework activities, insomnia state, appetite state, and sexual life state.

[0026]

[29] According to still another feature of the present invention, the questions may have a Cronbach's alpha coefficient of 0.75 or higher.

[30] According to still another feature of the present invention, the K-UCSQ may have a Cronbach's alpha coefficient of 0.94 or higher.

[0027]

[31] Furthermore, to solve the above-described problems, the present invention provides a device for providing information related to ulcerative colitis, comprising a communication unit configured to receive a K-UCSQ score for an individual, and a processor connected to the communication unit, wherein the processor is configured to determine the prognosis of inflammatory bowel disease for the individual based on the received K-UCSQ score.

[0028]

[32] According to a feature of the present invention, the inflammatory bowel disease may include, but is not limited to, ulcerative colitis (UC) and Crohn's disease (CD).

[0029]

[33] According to still another feature of the present invention, the processor may be configured to determine that the lower the received K-UCSQ score is, the more negative the prognosis of the overall health related to the individual's ulcerative colitis is.

[0030]

[34] According to still another feature of the present invention, the processor may be configured to determine that the higher the received K-UCSQ score is, the more positive the quality of life related to the individual's ulcerative colitis is.

[0031]

[35] According to still another feature of the present invention, the quality of life may be, but is not limited to, the quality of life in the 2 weeks before the K-UCSQ score is measured.

[36] According to still another feature of the present invention, the K-UCSQ may include questions related to at least one of an intestinal symptom domain, a toilet domain, a functional symptom domain, and a domain related to the impact on daily life.

[0032]

[37] According to still another feature of the present invention, the intestinal symptom domain may include questions related to at least one of the number of defecations, defecation state, presence or absence of bloody stool, amount of bloody stool, and fecal incontinence.

[38] According to yet another feature of the present invention, the toilet area may include questions relating to at least one of the following: stress of defecation, anxiety about the availability of toilets, ease of access to toilets, presence or absence of urgency to defecate, and location of toilets.

[0033]

[39] According to yet another feature of the present invention, the functional symptom area may include questions relating to at least one of the following: the number of times abdominal pain occurs, the presence or absence of pain other than abdominal pain, the location of abdominal pain, the presence or absence of abdominal gas, fatigue, malaise, and stress.

[0034]

[40] According to yet another feature of the present invention, the area relating to the impact on daily life may include questions relating to at least one of the following: sleep state, eating state, emotional state, self-denial, suicidal ideation, depressive state, social activity, household activity, insomnia, appetite state, and sexual life state. [Effects of the Invention]

[0035]

[41] The present invention can rapidly diagnose the prognosis of an individual with inflammatory bowel disease, particularly ulcerative colitis, and objectively provide related information.

[42] More specifically, the present invention makes it possible to determine and predict the prognosis with high accuracy specifically for ulcerative colitis by using K-UCSQ, an evaluation tool that has high reliability in ulcerative colitis.

[0036]

[43] Furthermore, the present invention enables rapid determination of information regarding the overall health of an individual with ulcerative colitis, and if the individual's health is negative, it enables rapid feedback to be provided to the individual, the individual's caregiver and healthcare provider, and enables rapid medical intervention for the individual's ulcerative colitis.

[0037]

[44] In other words, the present invention makes it possible to predict whether recovery from inflammatory bowel diseases, including ulcerative colitis, is possible, thereby enabling healthcare professionals to quickly make a diagnosis of ulcerative colitis in an individual and to expect a positive prognosis for ulcerative colitis. Furthermore, unnecessary medical prescriptions and treatments can be minimized, thereby reducing the time and cost burden on the individual (patient).

[0038]

[45] Furthermore, by being specific to ulcerative colitis, the present invention overcomes the limitations of conventional assessment tools that have failed to reflect the overall health and quality of life of individuals with ulcerative colitis.

[0039]

[46] The effects of the present invention are not limited to those exemplified above, and a wider variety of effects are included herein. [Brief explanation of the drawing]

[0040] [Figure 1]

[47] This is a flowchart of a method for providing information on ulcerative colitis according to one embodiment of the present invention. [Figure 2]

[48] ​​This is a schematic diagram illustrating a system based on an embodiment of the present invention concerning a method for providing information on ulcerative colitis. [Figure 3]

[49] This is a block diagram of a device 100 for providing information on ulcerative colitis according to one embodiment of the present invention. [Figure 4]

[50] This is a flowchart of the K-UCSQ development process. [Figure 5a]

[51] This is a schematic diagram of a draft (ver. 1.0) of K-UCSQ used in the method for providing information on ulcerative colitis according to one embodiment of the present invention. [Figure 5b]

[51] This is a schematic diagram of a draft (ver. 1.0) of K-UCSQ used in the method for providing information on ulcerative colitis according to one embodiment of the present invention. [Figure 5c]

[51] This is a schematic diagram of a draft (ver. 1.0) of K-UCSQ used in the method for providing information on ulcerative colitis according to one embodiment of the present invention. [Figure 6]

[52] The results of the demographic and disease-related characteristics of individuals who participated in a field test of the K-UCSQ used in an information provision method for ulcerative colitis according to one embodiment of the present invention. [Figure 7]

[53] This is the result of factor analysis on the questions in the draft K-UCSQ (ver. 1.0). [Figure 8a]

[54] This is a schematic diagram of the final K-UCSQ (ver. 1.1) used in the method for providing information on ulcerative colitis according to one embodiment of the present invention. [Figure 8b]

[54] This is a schematic diagram of the final K-UCSQ (ver. 1.1) used in the method for providing information on ulcerative colitis according to one embodiment of the present invention. [Figure 9]

[55] This is the result of reliability verification of the K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention. [Figure 10]

[56] This is the result of a homogeneity test between the K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention and the conventional evaluation tool IBDQ. [Figure 11]

[57] This shows the correlation between K-UCSQ, used in the information provision method for ulcerative colitis according to one embodiment of the present invention, and IBDQ, a conventional evaluation tool. [Figure 12]

[58] This is a general health prediction result of the information provision method for ulcerative colitis according to one embodiment of the present invention. [Figure 13]

[59] This is a prediction result of quality of life for a method of providing information on ulcerative colitis according to one embodiment of the present invention. [Modes for carrying out the invention]

[0041]

[60] The present invention will be described in more detail below through examples. However, these examples are for illustrative purposes only and should not be construed as limiting the scope of the present invention.

[0042]

[61]

[62] The advantages and features of the present invention, as well as methods for achieving them, will become apparent by referring to the embodiments described below in detail with the accompanying drawings. However, the present invention is not limited to the embodiments disclosed below and can be embodied in a variety of different forms, and these embodiments are provided merely to complete the disclosure of the present invention and to fully inform those who are ordinary skill in the art to which the present invention pertains, and the present invention is defined only by the claims.

[0043]

[63] As used herein, the term “or” means “and / or” unless otherwise specified.

[64] As used herein, the term “about” refers to the normal range of error for each value which is readily known to those skilled in the art. “About” values ​​or parameters as used herein include examples relating to the value or parameter itself. Furthermore, unless otherwise stated or otherwise evident from the context, the term “about” refers to a range of values ​​which corresponds to within 10 percent in either direction (greater than or less than) the reference value mentioned.

[0044]

[65] The term “patient or individual” as used herein is interchangeable and refers to any single animal, more preferably a mammal, in need of treatment (including non-human animals such as cats, dogs, horses, rabbits, zoo animals, cattle, pigs, sheep, and non-human primates). In the various embodiments herein, the patient referred to may be a human.

[0045]

[66]

[67] Method for providing information on ulcerative colitis according to one embodiment of the present invention and system based thereon

[68]

[69] The following describes, with reference to Figures 1 to 3, an embodiment of the present invention concerning a method for providing information on ulcerative colitis and a system based thereon.

[0046]

[70] Figure 1 is a flowchart of a method for providing information on ulcerative colitis according to one embodiment of the present invention. For the sake of explanation, the following table 1 will be used for reference.

[71] [Table 1] [Table 1-1] [Table 1-2]

[0047]

[72] Referring to Table 1, an embodiment of the present invention provides a method for providing information on ulcerative colitis, which includes the steps of receiving a K-UCSQ score for an individual (S110) and determining the prognosis of inflammatory bowel disease for the individual based on the received K-UCSQ score (S120).

[0048]

[73] In this case, the method for providing information on ulcerative colitis according to one embodiment of the present invention can be embodied by a processor.

[74] Furthermore, in a method for providing information on ulcerative colitis according to one embodiment of the present invention, inflammatory bowel disease (IBD) is a disease that causes chronic inflammation of unknown cause in the intestinal tract and may include ulcerative colitis (UC) and Crohn's disease (CD). More specifically, ulcerative colitis is characterized by continuous inflammation occurring in the rectum, which is localized to the large intestine, i.e., the colon, and presents with symptoms such as mucous stools, bloody stools, diarrhea, and urgency to defecate. In contrast, Crohn's disease is characterized by discontinuous inflammation occurring in various sites from the mouth to the anal canal, and presents with symptoms such as abdominal pain, cramps, and weight loss. In other words, ulcerative colitis and Crohn's disease can be distinguished by differences in pathophysiology and symptoms.

[0049]

[75] First, at the receiving stage (S110), the individual may, but may not be, an individual with inflammatory bowel disease or suspected thereof.

[76] Furthermore, at the reception stage (S110), K-UCSQ can mean a disease-specific assessment tool for inflammatory bowel disease, and in particular, K-UCSQ may be, but is not limited to, an assessment tool specifically for ulcerative colitis among inflammatory bowel diseases.

[0050]

[77] More specifically, referring to Table 1, the KUCSQ used in the method for providing information on ulcerative colitis according to one embodiment of the present invention is shown.

[78] The K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention is a Korean-style questionnaire specifically for patients with ulcerative colitis, and can evaluate and reflect the quality of life (QoL) for ulcerative colitis with higher accuracy and reliability than conventional evaluation tools.

[0051]

[79] The K-UCSQ consists of 28 questions that individuals, i.e., patients themselves, answer about their health status over the past two weeks, and the 28 questions can be measured using the Likert scale. For example, each question in the K-UCSQ is structured to be answered using one of five scales, including “Always (strongly agree),” “Almost (agree),” “Sometimes (normal),” “Rarely (disagree),” and “Never (strongly disagree),” which can be scored as 5, 4, 3, 2, and 1, respectively, but are not limited to these.

[0052]

[80] Furthermore, the K-UCSQ, which consists of 28 questions, is calculated based on the Likert scale as mentioned above, and can therefore be scored from 28 to 140 points.

[81] Furthermore, the K-UCSQ is divided into five domains, which may include a general health domain with one question, a bowel symptoms domain with five questions, a toilet domain with five questions, a functional symptoms domain with seven questions, and an impact on daily life domain with eleven questions.

[0053]

[82] More specifically, the bowel symptoms area, which includes five questions, includes questions related to the frequency of bowel movements, the state of bowel movements, the presence or absence of blood in the stool, the amount of blood in the stool, and fecal incontinence.

[83] In addition, the toilet area, which includes five questions, includes questions about defecation stress, anxiety about toilet availability, ease of access to toilets, presence or absence of urgency to defecate, and toilet location.

[0054]

[84] In addition, the functional symptom area, which includes seven questions, includes questions related to the frequency of abdominal pain, the presence or absence of pain other than abdominal pain, the location of abdominal pain, the presence or absence of abdominal gas, fatigue, malaise, and stress.

[0055]

[85] In addition, the domain concerning the impact on daily life, which includes 11 questions, includes questions concerning sleep patterns, eating patterns, emotional states, self-denial, suicidal thoughts, depressive states, social activities, household activities, insomnia, appetite, and sexual life.

[0056]

[86] This allows the K-UCSQ to index and measure an individual's concerns or interests related to inflammatory bowel disease, i.e., ulcerative colitis, using 28 questions.

[0057]

[87] Referring again to Figure 1, at the receiving stage (S110), the K-UCSQ may have a Cronbach's alpha coefficient of 0.94 or higher. That is, the K-UCSQ has a Cronbach's alpha coefficient of 0.7 or higher, which is a high reliability threshold, and therefore can be said to be a highly reliable evaluation tool.

[0058]

[88] Accordingly, the method for providing information on ulcerative colitis according to one embodiment of the present invention can more accurately predict and evaluate the prognosis for ulcerative colitis based on the highly reliable K-UCSQ quality of life scale for patients with ulcerative colitis.

[0059]

[89] Next, in the decision stage (S120), the lower the received K-UCSQ score, the more negative the overall health prognosis for the individual related to ulcerative colitis can be determined.

[0060]

[90] Furthermore, at the decision stage (S120), a higher K-UCSQ score received can be determined to indicate a more positive quality of life associated with ulcerative colitis in the individual.

[91] Through the above process, the method for providing information on ulcerative colitis according to one embodiment of the present invention can predict and evaluate the prognosis of individuals with inflammatory bowel disease, particularly ulcerative colitis.

[0061]

[92] Furthermore, the method for providing information on ulcerative colitis according to one embodiment of the present invention, based on the highly reliable K-UCSQ, allows for more accurate diagnosis and confirmation of the current state of an individual regarding ulcerative colitis.

[0062]

[93] Figure 2 is a schematic diagram illustrating a system based on an embodiment of the present invention concerning a method for providing information on ulcerative colitis. For the sake of explanation, the following will be explained with reference to Figure 3.

[0063]

[94] Referring to Figure 2, a system 1000 based on an information provision method for ulcerative colitis according to one embodiment of the present invention includes an information provision device 100 for ulcerative colitis, a user device 200, a medical server 300, and a DB 400.

[0064]

[95] At this time, the ulcerative colitis information-providing device 100, the user device 200, the medical server 300, and the DB 400 can send and receive a variety of information via wired or wireless communication. More specifically, the ulcerative colitis information-providing device 100, the user device 200, the medical server 300, and the DB 400 can communicate via wired communication, where they are directly connected and transmit / receive data via cables, but preferably they can communicate wirelessly, where cables are omitted and data is transmitted / received wirelessly. Therefore, the ulcerative colitis information provision device 100, user device 200, medical server 300, and DB 400 may be connected to a network for wireless communication, and the network may be a closed network such as a LAN (Local Area Network) and a WAN (Wide Area Network), or an open network such as the Internet, and may be, but is not limited to, a short-range wireless communication such as Bluetooth®, NFC (Near Field Communication), RFID (Radio-Frequency Identification), Wi-Fi and / or Zigbee®.

[0065]

[96] First, the ulcerative colitis information provision device 100 means a device that analyzes the KUCSQ score for an individual and determines and provides various information about the individual's ulcerative colitis, namely prognosis, health status and quality of life. The ulcerative colitis information provision method device 100 collects various data received from the user device 200 and the medical server 300. The ulcerative colitis information provision method device 100 may also include a general-purpose computer, laptop, data server, etc., for analyzing the collected data and determining (calculating) and providing various information about ulcerative colitis.

[0066]

[97] More specifically, referring to Figure 3, a block diagram of an information-providing device 100 for ulcerative colitis according to one embodiment of the present invention is shown.

[98] The ulcerative colitis information-providing device 100 includes a communication unit 110, a storage unit 120, a power supply unit 130, and a processor 140.

[0067]

[99] The communications unit 110 connects the ulcerative colitis information provision device 100 to the user device 200, the medical server 300, and the DB 400 so that they can communicate with each other.

[0100] The communication unit 110 can use wired / wireless communication to connect the ulcerative colitis information provision device 100 to the user device 200, the medical server 300, and the DB 400, and send and receive various types of data.

[0068]

[0101] The storage unit 120 stores data about the individual received and collected via the communication unit 110, namely the score for K-UCSQ and information about ulcerative colitis determined based on that score.

[0069]

[0102] The storage unit 120 may include at least one type of storage medium from among flash memory type, hard disk type, multimedia card micro type, card type memory (e.g., SD or XD memory), RAM (Random Access Memory), SRAM (Static Random Access Memory), ROM (Read-Only Memory), EEPROM (Electrically Erasable Programmable Read-Only Memory), PROM (Programmable Read-Only Memory), magnetic memory, magnetic disk, and optical disk. The ulcerative colitis information providing device 100 may also operate in conjunction with web storage that performs the storage function of the storage unit 120 over the internet.

[0070]

[0103] The power supply unit 130 is configured to supply power to the ulcerative colitis information provision device 100.

[0104] The processor 140 is operablely connected to the communication unit 110, the storage unit 120, and the power supply unit 130, and executes a variety of commands to determine and provide a variety of information about an individual's ulcerative colitis. The following briefly describes the operation of determining and providing a variety of information about an individual's ulcerative colitis to the user.

[0071]

[0105] The processor 140 may be configured to receive score data collected from the K-UCSQ for individuals with or suspected of having ulcerative colitis, and related data collected from the individual or their guardian, from the communication unit 110, and to determine the prognosis of ulcerative colitis. More specifically, the processor 140 can determine (predict) the overall health prognosis, quality of life, and health status of the individual related to ulcerative colitis based on the received K-UCSQ score.

[0072]

[0106] Next, the processor 140 is configured to provide the user device with the prognosis of the determined individual's ulcerative colitis and related data via the communication unit 110.

[0107] On the other hand, the processor 140 can use a predictive model configured to determine (predict) the prognosis for ulcerative colitis, but is not limited thereto. By using the predictive model, the device 100 for providing information on ulcerative colitis according to one embodiment of the present invention can further include a modeling unit.

[0073]

[0108] More specifically, the modeling unit can model the correlation between collected K-UCSQ scores and general health data regarding ulcerative colitis collected from individuals by applying a logistic regression model.

[0074]

[0109] Referring again to Figure 2, the user device 200 means a device that can receive information about an individual's ulcerative colitis from the ulcerative colitis information providing device 100, and further, the user device 200 may mean a device that can provide diverse information about an individual to the ulcerative colitis information providing device 100.

[0075]

[0110] More specifically, the user device 200 may be a device capable of providing K-UCSQ to an individual (patient) with an inflammatory bowel disease such as ulcerative colitis or Crohn's disease. For example, the user device 200 may include, but is not limited to, an interface screen that allows the individual's guardian to record and display the individual's symptoms. Furthermore, the user device 200 may be, but is not limited to, a smartphone, tablet, PC, wearable device, PC or smart TV, LED SIGN, etc., with applications, programs, widgets or a web browser installed.

[0076]

[0111] In other words, in a system based on an information provision method for ulcerative colitis according to one embodiment of the present invention, data related to K-UCSQ for an individual can be collected from a user device 200.

[0077]

[0112] Medical server 300 may refer to a medical information system in a hospital or public healthcare institution where the age, sex, marital status, educational background, and medical records (medical charts) of individuals (patients) with or suspected of having inflammatory bowel disease are stored.

[0078]

[0113] In other words, in a system based on an information provision method for ulcerative colitis according to one embodiment of the present invention, the K-UCSQ test is recorded by a hospital or public medical institution, and related data, including the K-UCSQ score, can be collected not only from the user device 200 but also from the medical server 300.

[0079]

[0114] DB400 can collect data received by the ulcerative colitis information provision device 100 and store information about ulcerative colitis provided based on the collected data. In other words, the ulcerative colitis information provision device 100 can store K-UCSQ-related data and information about ulcerative colitis of individuals determined based on this data in the DB.

[0080]

[0115] DB400 is connected to the ulcerative colitis information provision device 100, and can convert and store various data received from the user device 200 and the medical server 300 from the ulcerative colitis information provision device 100.

[0081]

[0116] Through the above process, the ulcerative colitis information provision device 100 according to one embodiment of the present invention can collect various data about an individual from a medical institution and / or a user device, and based on this, provide information about the individual's ulcerative colitis.

[0082]

[0117]

[0118] Development of K-UCSQ used in an information provision method for ulcerative colitis according to one embodiment of the present invention

[0119]

[0120] The development process of K-UCSQ, used in an information provision method for ulcerative colitis according to one embodiment of the present invention, will be described below with reference to Figures 4 to 8b.

[0083]

[0121] First, Figure 4 is a flowchart of the K-UCSQ development process. For the sake of explanation, we will refer to Figures 5a to 8b.

[0122] The K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention was developed through a process of concept setup, raw scale construction, empirical verification, derivation of K-UCSQ version 1.0 (UCSQ ver 1.0 finalization), multicenter field testing, factor analysis, and validation.

[0084]

[0123] More specifically, during the conceptualization phase, an advisory board meeting was held with a total of seven members (six professors related to gastroenterology and one biostatistician) to discuss concepts related to the signs, symptoms, systemic symptoms, and management of ulcerative colitis, a type of inflammatory bowel disease, as well as their opinions on the conventional assessment tool, IBDQ.

[0085]

[0124] As a result, through the aforementioned advisory committee meetings, an initial draft plan for the structure (items), format, and scoring of the K-UCSQ was established.

[0125] Next, we conducted in-depth interviews with two gastroenterology specialists to select questions for the K-UCSQ initial draft.

[0086]

[0126] Next, for pilot testing, a biostatistician defined the question domains and Likert scales for the initial draft of the K-UCSQ, and empirical verification was conducted through meetings with four ulcerative colitis patients.

[0087]

[0127] Next, based on the results of the meetings with ulcerative patients, the final draft of the K-UCSQ (ver. 1.0) was decided through a second meeting of the advisory committee.

[0128] Referring to Figures 5a and 5b, we see the draft K-UCSQ (ver. 1.0) developed through the procedure described above. The draft K-UCSQ (ver. 1.0) consists of a total of 39 questions and is divided into seven domains, including defecation, pain / discomfort, toilet use, fatigue / energy, disease-related psychology, the impact of the disease on daily life, and medication adherence (past two weeks).

[0088]

[0129] Furthermore, the evaluation tool used in the method for providing information on ulcerative colitis according to one embodiment of the present invention, namely K-UCSQ, may include not only the questions described above but also questions concerning the background information of the subjects.

[0089]

[0130] More specifically, referring to Figure 5c, the background information questions of the K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention are shown. The K-UCSQ may further include questions regarding background information of an individual (subject), such as gender, marital status, date of birth, place of residence, smoking, drinking, occupation or enrollment, workplace information, school information, year of diagnosis of gastric ulcerative colitis, severity, and medications taken.

[0090]

[0131] Therefore, the method for providing information on ulcerative colitis according to one embodiment of the present invention allows for more accurate determination (prediction) of the prognosis and related information of an individual's ulcerative colitis because the K-UCSQ itself contains clinical information about the individual.

[0091]

[0132] Referring again to Figure 4, after the K-UCSQ version 1.0 derivation stage, a multi-center field test was conducted.

[0133] More specifically, the study protocol for K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention was approved by the Yonsei University Institute of Health Sciences Institutional Review Committee (No. 2-2018-0300), Seoul National University Institute of Health Sciences (No. H-1812-043-993), Samsung Seoul Hospital (No. SMC 2018-09-104), Gangbuk Samsung Hospital (No. KBSMC 2018-09-039), Asan Medical Center (No. 2018-11), and Korea University Health System (No. 2018AN0360).

[0092]

[0134] In this regard, Figure 6 shows the demographic and disease-related characteristics of individuals who participated in a field test of the K-UCSQ used in an information provision method for ulcerative colitis according to one embodiment of the present invention.

[0093]

[0135] The field test of the K-UCSQ draft (ver. 1.0) was conducted on 200 ulcerative colitis patients registered at Severance Hospital, Seoul National University Hospital, Samsung Seoul Hospital, Gangbuk Samsung Hospital, Seoul Asan Hospital, and Korea University Hospital. The K-UCSQ draft (ver. 1.0) was created simultaneously with the development of the conventional assessment tool, IBDQ. The patients who participated in the field test were individuals diagnosed with ulcerative colitis, who understood the purpose and procedures of this study, who voluntarily agreed to participate, and who were literate and literate. Furthermore, the severity of ulcerative colitis was assessed based on the Mayo score system.

[0094]

[0136] First, it was shown that the average age of the individuals who participated in the field test was 43.7 years, with 123 males (61.5%) and 77 females (38.5%).

[0095]

[0137] Next, it was shown that 123 people (61.5%) were married, and 77 people (38.5%) were unmarried.

[0138] Next, it was shown that 138 participants (69.0%) were non-smokers (never), 39 participants (19.5%) were former / past smokers, and 22 participants (11.0%) were current smokers (within the last 6 months). It was also shown that the smoking status of one participant (0.5%) was missing.

[0096]

[0139] Next, it was shown that 199 individuals (59.5%) did not drink alcohol at all, 56 individuals (28.0%) drank 3 drinks or less per week, 16 individuals (8.0%) drank 4 to 14 drinks per week, and 9 individuals (4.5%) drank 15 drinks or more per week.

[0097]

[0140] Next, it was shown that 139 individuals (69.5%) were employed or enrolled in school, while 61 individuals (30.5%) were neither employed nor enrolled in school.

[0141] Next, it was shown that the average duration of ulcerative colitis in individuals participating in the field test was 6.7 years.

[0098]

[0142] Finally, regarding the severity of ulcerative colitis, 114 patients (57.0%) were in remission, 67 patients (33.5%) were mild, 17 patients (8.5%) were moderate, and 2 patients (1.0%) were severe.

[0099]

[0143] Next, referring again to Figure 4, a factor analysis was performed based on the field test results, and questions that did not contribute to the major areas identified by the factor analysis were removed from the K-UCSQ draft (ver. 1.0).

[0100]

[0144] More specifically, Figure 7 shows the results of factor analysis on the questions of the K-UCSQ draft (ver. 1.0). In this analysis, Promax rotation was used to confirm the influence of each question in each domain, and the factor structure rotated accordingly was examined. Furthermore, factors with a factor loading of 0.40 or higher were judged to be significant, and those with a factor loading of less than 0.40 were excluded. Questions with a factor loading of 0.40 or higher may indicate discriminatory power in the relevant domain.

[0101]

[0145] First, it was shown that questions Q1, Q2, Q4, Q5, and Q8 had the highest values ​​in the intestinal symptom area, at 43, 50, 62, 62, and 43 respectively, meaning that questions Q1, Q2, Q4, Q5, and Q8 have the greatest impact on the intestinal symptom area.

[0102]

[0146] Therefore, the questions related to the intestinal symptoms area of ​​the K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention may include Q1, Q2, Q4, Q5, and Q8.

[0103]

[0147] Next, it was shown that Q13, Q14, Q15, Q16, and Q17 showed the highest values ​​in the toilet area, at 65, 81, 82, 67, and 87 respectively, which could mean that questions Q13, Q14, Q15, Q16, and Q17 have the greatest impact on the toilet area.

[0104]

[0148] Therefore, the questions related to the toilet area of ​​the K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention may include Q1, Q2, Q4, Q5, and Q8.

[0105]

[0149] Next, it was shown that Q9, Q10, Q11, Q12, Q18, Q19, and Q22 showed the highest values ​​in the functional symptom domain, which may mean that questions Q9, Q10, Q11, Q12, Q18, Q19, and Q22 have the greatest impact on the functional symptom domain.

[0106]

[0150] Therefore, the questions concerning the functional symptom area of ​​the K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention may include Q9, Q10, Q11, Q12, Q18, Q19, and Q22.

[0107]

[0151] Next, it was shown that Q3, Q6, Q24, Q25, Q26, Q27, Q28, Q29, Q30, Q31, and Q32 have the highest values ​​in the area of ​​impact on daily life, which may mean that questions Q3, Q6, Q24, Q25, Q26, Q27, Q28, Q29, Q30, Q31, and Q32 have the greatest impact in the area of ​​impact on daily life.

[0108]

[0152] Therefore, the domain questions regarding the impact of the K-UCSQ on daily life used in the information provision method for ulcerative colitis according to one embodiment of the present invention may include Q3, Q6, Q24, Q25, Q26, Q27, Q28, Q29, Q30, Q31, and Q32.

[0109]

[0153] Finally, Q7, Q20, Q21, and Q23 were shown to have no association with the respective domains due to their factor loadings being less than 0.40, and were therefore removed from the final K-UCSQ (ver. 1.1).

[0110]

[0154] Referring again to Figure 4, the final K-UCSQ (ver. 1.1), which includes four domains and 28 questions, was developed through the third meeting of the advisory committee based on the results in Figure 7 mentioned above.

[0111]

[0155] In this regard, referring to Figures 8a and 8b, the final K-UCSQ (ver. 1.1) is shown, which is a questionnaire specifically designed to measure health-related quality of life in individuals with ulcerative colitis, a type of inflammatory bowel disease.

[0112]

[0156] Furthermore, each item in the final K-UCSQ (ver. 1.1) is scored on a 5-point Likert scale, with the overall score ranging from at least 28 to a maximum of 140 points. A higher score may indicate a more positive health and related quality of life for individuals with ulcerative colitis.

[0113]

[0157] Through the above process, the K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention can be specialized for individuals including those with ulcerative colitis, and can have higher reliability and accuracy.

[0114]

[0158]

[0159] Confirmation and Verification of a Method for Providing Information on Ulcerative Colitis According to One Embodiment of the Present Invention

[0160]

[0161] The following describes the confirmation and verification results of an information provision method for ulcerative colitis according to one embodiment of the present invention, with reference to Figures 9 to 13.

[0115]

[0162] Figure 9 shows the results of reliability verification of the K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention. In this case, reliability is evaluated through the Cronbach's alpha coefficient, and a Cronbach's alpha coefficient of 0.70 or higher may indicate high reliability suitable for analysis and utilization.

[0116]

[0163] Referring to Figure 9, the Cronbach's alpha coefficient for the intestinal symptom region is shown to be 0.75, which suggests that the questions related to the intestinal symptom region in the K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention may have high reliability.

[0117]

[0164] The Cronbach's alpha coefficient for the toilet area has been shown to be 0.94, which suggests that the questions related to the toilet area of ​​the K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention have high reliability.

[0118]

[0165] The Cronbach's alpha coefficient for the functional symptom domain has been shown to be 0.85, which suggests that the questions concerning the functional symptom domain in the K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention may have high reliability.

[0119]

[0166] The Cronbach's alpha coefficient for the domain related to the impact on daily life has been shown to be 0.90, which suggests that the questions in the domain related to the impact on daily life of the K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention may have high reliability.

[0120]

[0167] Therefore, it has been shown that the Cronbach's alpha coefficient of the K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention is 0.94, which may mean that the K-UCSQ has high reliability as a tool for confirming and predicting the overall health status and quality of life of the body in ulcerative colitis.

[0121]

[0168] Figure 10 shows the results of the homogeneity test between the K-UCSQ, used in the information provision method for ulcerative colitis according to one embodiment of the present invention, and the conventional evaluation tool, IBDQ.

[0169] In this study, the K-UCSQ had a score range of 28 to 140 points, with the measured total scores distributed between 66 and 140 points, and the mean was 119.5 ± 17.1 points. Furthermore, the IBDQ had a score range of 32 to 224 points, with the measured total scores distributed between 64 and 224 points, and the mean was 178.8 ± 31.5 points. The Spearman rank-correlation coefficient between the K-UCSQ and IBDQ was 0.875 (P-value < 0.001), which may indicate a positive correlation.

[0122]

[0170] The homogeneity test described below uses McNemar's test (either the Stuart-Maxwell test or the Bhapkar test) to confirm the marginal homogeneity of the decile distributions of total scores between the K-UCSQ and IBDQ. Score groups by decile refer to groups obtained by dividing the scores from the lowest to the highest into 10 equal parts.

[0123]

[0171] Referring to Figure 10, it can be seen that the decile groups of K-UCSQ and IBDQ are in perfect agreement along the diagonal, which may mean that the scores of K-UCSQ and IBDQ exhibit high homogeneity.

[0124]

[0172] Furthermore, the p-values ​​for the Stuart-Maxwell assay and the Bhapkar assay were 0.647 and 0.615, respectively, demonstrating a high degree of agreement between K-UCSQ and IBDQ.

[0125]

[0173] In other words, the K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention has a high degree of homogeneity with the conventional evaluation tool IBDQ, and therefore can be used in general.

[0126]

[0174] Figure 11 shows the results of the correlation between the K-UCSQ, used in an information provision method for ulcerative colitis according to one embodiment of the present invention, and the conventional assessment tool, IBDQ. In this case, the correlation was measured using the mean standardized scores of the K-UCSQ and IBDQ, and further refined according to the severity of ulcerative colitis (remission, mild, moderate, and severe) to measure the correlation.

[0127]

[0175] First, the individuals used to calculate the correlations totaled 200 individuals with ulcerative colitis, as shown in Figure 6. These included 114 individuals in remission, 67 individuals with mild symptoms, and 19 individuals with moderate to severe symptoms. The average K-UCSQ scores for each group were 125.15 for remission, 116.78 for mild symptoms, and 94.84 for severe to mild symptoms, while the overall average score was 119.47.

[0128]

[0176] Furthermore, the K-UCSQ score (variable) was divided into minimum (min), first quartile (Q1), median, third quartile (Q3), and maximum (max) values ​​according to the severity of ulcerative colitis, and their distributions were compared. More specifically, for 114 individuals in remission, the K-UCSQ scores were distributed as follows: 81, 119, 129, 134, and 140 points. For 67 individuals with mild symptoms, the scores were distributed as follows: 72, 106, 120, 132, and 140 points. For 19 individuals with both severe and mild symptoms, the scores were distributed as follows: 66, 81, 94, 109, and 122 points. For the total of 200 individuals, the scores were distributed as follows: 66, 110, 124, and 140 points.

[0129]

[0177] Specifically, approximately 75% of individuals with remission or mild symptoms were ranked in the top 75% of all individuals in terms of total K-UCSQ scores, while approximately 75% of individuals with severe or mild symptoms were ranked in the bottom 25% of all individuals in terms of total K-UCSQ scores.

[0130]

[0178] Referring to Figure 11, the slope of the linear regression line between K-UCSQ and IBDQ is 0.954, indicating a linear relationship and potentially a high correlation.

[0179] Furthermore, the mean standardized scores for K-UCSQ for remission, mild, moderate, and severe cases were 0.332, -0.157, and -1.436, respectively, which are similar to the mean standardized scores for IBDQ (0.354, -0.218, and -1.358), suggesting that K-UCSQ may also have a high correlation with disease symptoms.

[0131]

[0180] In other words, the K-UCSQ used in the information provision method for ulcerative colitis according to one embodiment of the present invention may have superior internal consistency and validity compared to the conventional evaluation tool IBDQ.

[0132]

[0181] Figure 12 shows the overall health prediction results of an information provision method for ulcerative colitis according to one embodiment of the present invention. In this case, the overall health prediction was made by comparing AUC using a logistic regression model, and the mean standardized scores of K-UCSQ and IBDQ were used as predictor variables in the model.

[0133]

[0182] Referring to Figure 12, the AUC for overall health of the information provision method for ulcerative colitis (UCSQ) according to one embodiment of the present invention was 0.812, which is higher than the 0.797 of the conventional assessment tool IBDQ. In other words, the information provision method for ulcerative colitis according to one embodiment of the present invention may have higher predictive accuracy for overall health than conventional assessment tools.

[0134]

[0183] Therefore, the method for providing information on ulcerative colitis according to one embodiment of the present invention can use a predictive model configured to determine the overall health prognosis for ulcerative colitis, in which case the predictive model may be a model generated by applying a logistic regression model based on the correlation between the K-UCSQ score and the outcome for overall health.

[0135]

[0184] Figure 13 shows the predictive results for quality of life of an information provision method for ulcerative colitis according to one embodiment of the present invention. In this case, the prediction of quality of life was made by comparing AUC using a logistic regression model, and the mean standardized scores of K-UCSQ and IBDQ were used as predictor variables in the model.

[0136]

[0185] Referring to Figure 13, the AUC for quality of life of the information provision method for ulcerative colitis according to one embodiment of the present invention (UCSQ) is 0.864, which is higher than the 0.859 of the conventional evaluation tool IBDQ. In other words, the information provision method for ulcerative colitis according to one embodiment of the present invention may have higher predictive accuracy in terms of quality of life than conventional evaluation tools.

[0137]

[0186] Therefore, the method for providing information on ulcerative colitis according to one embodiment of the present invention can use a predictive model configured to determine the prognosis of quality of life for ulcerative colitis, in which case the predictive model may be a model generated by applying a logistic regression model based on the correlation between the K-UCSQ score and the outcome regarding quality of life.

[0138]

[0187] Although embodiments of the present invention have been described in more detail above with reference to the attached drawings, the present invention is not necessarily limited to these embodiments and can be implemented in various ways without departing from the technical concept of the present invention. Therefore, the embodiments disclosed herein are for illustrative purposes only and not to limit the technical concept of the present invention, and the scope of the technical concept of the present invention is not limited by such embodiments. Accordingly, the embodiments described above should be understood to be illustrative and not limiting in all respects. The scope of protection of the present invention should be interpreted by the following claims, and all technical concepts within an equivalent scope should be interpreted as being included in the scope of the rights of the present invention.

Claims

1. A method for providing information about ulcerative colitis, which is embodied by a processor, The step of receiving the individual's K-UCSQ score, and A method for providing information on ulcerative colitis, comprising the step of determining the prognosis of the individual's inflammatory bowel disease based on the received K-UCSQ score.

2. The aforementioned inflammatory bowel disease is, A method for providing information on ulcerative colitis according to claim 1, including ulcerative colitis and Crohn's disease.

3. The aforementioned decision-making stage is, A method for providing information on ulcerative colitis according to claim 1, comprising the step of determining that the lower the received K-UCSQ score, the more negative the overall health prognosis related to ulcerative colitis for the individual.

4. The aforementioned decision-making stage is, A method for providing information on ulcerative colitis according to claim 1, comprising the step of determining that the higher the received K-UCSQ score, the more positive the quality of life of the individual related to ulcerative colitis.

5. The aforementioned quality of life is, The method for providing information on ulcerative colitis according to claim 4, which is the quality of life for two weeks prior to the measurement of the K-UCSQ score.

6. The aforementioned K-UCSQ is, A method for providing information on ulcerative colitis according to claim 1, comprising questions relating to at least one of the following areas: general health status, intestinal symptoms, toilet-related issues, functional symptoms, and impact on daily life.

7. The aforementioned area of ​​intestinal symptoms is, A method for providing information on ulcerative colitis according to claim 6, comprising questions relating to at least one of the following: frequency of defecation, defecation condition, presence or absence of blood in the stool, amount of blood in the stool, and fecal incontinence.

8. The aforementioned toilet area is A method for providing information on ulcerative colitis according to claim 6, comprising questions relating to at least one of the following: stress related to defecation, anxiety about the availability of toilets, ease of access to toilets, presence or absence of urgency to defecate, and location of toilets.

9. The aforementioned functional symptom area is, A method for providing information about ulcerative colitis according to claim 6, comprising questions relating to at least one of the following: the number of times abdominal pain occurs, the presence or absence of pain other than abdominal pain, the location of abdominal pain, the presence or absence of abdominal gas, fatigue, poor physical condition, and stress.

10. The area of ​​impact on daily life is, A method for providing information about ulcerative colitis according to claim 6, comprising questions relating to at least one of the following: sleep status, eating status, emotional state, self-denial, suicidal ideation, depressive state, social activities, household activities, insomnia, appetite, and sexual life.

11. The above question is, The method for providing information on ulcerative colitis according to claim 6, wherein the Crohnbach alpha coefficient is 0.75 or higher.

12. The aforementioned K-UCSQ is, A method for providing information on ulcerative colitis according to claim 1, wherein the Crohnbach alpha coefficient is 0.94 or higher.

13. A communications unit configured to receive the K-UCSQ score of an individual, and Includes a processor connected to the aforementioned communication unit, The aforementioned processor, A device for providing information on ulcerative colitis, configured to determine the prognosis of an individual's inflammatory bowel disease based on the received K-UCSQ score.

14. The aforementioned inflammatory bowel disease is, A device for providing information on ulcerative colitis according to claim 13, including ulcerative colitis and Crohn's disease.

15. The aforementioned processor, The ulcerative colitis information-providing device according to claim 13, configured to determine that the lower the received K-UCSQ score, the more negative the overall health prognosis related to ulcerative colitis for the individual.

16. The aforementioned processor, The ulcerative colitis information-providing device according to claim 13, configured to determine that the higher the received K-UCSQ score, the more positive the individual's quality of life related to ulcerative colitis.

17. The aforementioned quality of life, The device for providing information on ulcerative colitis according to claim 16, wherein the K-UCSQ score is the quality of life for two weeks prior to the measurement of the K-UCSQ score.

18. The aforementioned K-UCSQ is, A device for providing information on ulcerative colitis according to claim 13, comprising questions relating to at least one of the following areas: intestinal symptoms, toilet-related issues, functional symptoms, and impacts on daily life.

19. The aforementioned area of ​​intestinal symptoms is, A device for providing information about ulcerative colitis according to claim 18, comprising questions relating to at least one of the following: frequency of bowel movements, condition of bowel movements, presence or absence of blood in the stool, amount of blood in the stool, and fecal incontinence.

20. The aforementioned toilet area is A device for providing information about ulcerative colitis according to claim 18, comprising questions relating to at least one of the following: stress from defecation, anxiety about the availability of toilets, ease of access to toilets, presence or absence of urgency to defecate, and location of toilets.

21. The aforementioned functional symptom area is, A device for providing information about ulcerative colitis according to claim 18, comprising questions relating to at least one of the following: the number of times abdominal pain occurs, the presence or absence of pain other than abdominal pain, the location of abdominal pain, the presence or absence of abdominal gas, fatigue, poor physical condition, and stress.

22. The aforementioned area concerning the impact on daily life is, A device for providing information about ulcerative colitis according to claim 18, comprising questions relating to at least one of the following: sleep state, eating state, emotional state, self-denial, suicidal ideation, depressive state, social activity, household activity, insomnia, appetite state, and sexual life state.